文献速递血管炎其他结缔组织病类风湿关节炎

患者视角下风湿病全身性糖皮质激素治疗所致外貌与体重变化的影响

Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases.
PubMed 文献 · Rheumatology (Oxford) · 2025-01-01

该研究对英国、美国、澳大利亚60例接受糖皮质激素治疗的风湿病患者进行半结构化访谈的二次归纳主题分析,年龄26-84岁,65%为女性。识别出社会规范、心理健康与自我感损害、调整负担三个主题,患者将外貌变化归因于糖皮质激素并影响生活质量,作者建议满足患者信息与支持需求的方式可通过进一步工作开发。

要点

  • 患者将外貌变化归因于糖皮质激素治疗,并报告其对生活质量的多方面影响。
  • 识别出社会规范、心理健康与自我感损害、调整负担三个 overarching 主题。
  • 参与者表达需要更多信息和支持。

核心结论

  • 患者将多种生活质量影响归因于糖皮质激素相关的外貌变化。
  • 作者建议满足患者信息与支持需求的方式,可通过进一步工作开发。

研究设计与样本

  • 对「Steroid PRO」半结构化访谈进行二次归纳主题分析。
  • 纳入英国、美国、澳大利亚接受糖皮质激素治疗的风湿病患者,共分析60例访谈。
  • 患者年龄26-84岁,39例(65%)为女性。
  • 疾病包括全身性血管炎19例、炎症性关节炎14例、晶体性关节病2例、结缔组织病16例、其他/多种9例。

主要发现

  • 除参与者表达需要更多信息和支持外,识别出三个 overarching 主题:社会规范、心理健康与自我感损害、调整负担。
  • 社会规范主题包括参与者感到需要顺从的真实或感知期望,这些期望通过与他人互动得以维持。
  • 心理健康与自我感损害主题中,糖皮质激素被描述为使参与者「看起来不像」自己,与情绪和自信心变化相关。
  • 调整负担主题涉及饮食、运动、工作、爱好、日常生活活动和关键生活事件的调整。

临床怎么用

  • 作者建议满足患者信息与支持需求的方式,可通过进一步工作开发。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore patients' perspectives on the impact of appearance changes attributed to glucocorticoid treatment. METHODS: A secondary inductive thematic analysis was conducted of the 'Steroid PRO' semi-structured interviews with patients with rheumatic conditions receiving glucocorticoids in the UK, USA and Australia. RESULTS: Sixty patient interviews were analysed. Patient age was 26-84 years; 39 (65%) were female; and the patients had systemic vasculitis (n = 19), inflammatory arthritis (n = 14), crystal arthropathy (n = 2), connective tissue disorders (n = 16) or other/multiple (n = 9). In addition to participants expressing the need for more information and support, three over-arching themes were identified: (i) societal norms ['I think my main concern, particularly being female, was the weight gain that the steroids had' (female aged 26-30)]; these included real or perceived expectations to which participants felt pressure to conform, which were sustained through interactions with others; (ii) harms to mental health and sense of self ['It makes you feel down. It makes you feel depressed. You don't want to socialize because you're not you' (male aged 61-65)]; glucocorticoids were described as making participants 'not look like' themselves, associated with changes in mood and self-confidence; and (iii) burden of adjustments ['I have a wardrobe right now that goes four different sizes' (female aged 51-55)]; other adjustments related to diet, exercise, work, hobbies, activities of daily living and key life events. CONCLUSION: Patients attribute a variety of impacts on their quality of life to glucocorticoid-related appearance changes. We suggest ways to meet patients' needs for information and support, which can be developed through further work.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Lax SJ, Dures E, Bridgewater S, et al. Patient perspectives on the impact of appearance and weight changes attributed to systemic glucocorticoid treatment of rheumatic diseases. Rheumatology (Oxford). 2025. PMID: 40037582. doi:10.1093/rheumatology/keaf121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。